University of California San Francisco
Give to UCSF
An inexpensive, hundred-year-old therapy for pain – aspirin – is effective in high doses for the treatment of severe headache and migraine caused by drug withdrawal, according to a new study by researchers with the UCSF Headache Center.
In neurodegenerative diseases, clumps of insoluble proteins appear in patients’ brains. These aggregates contain proteins that are unique to each disease, such as amyloid beta in Alzheimer’s disease, but they are intertwined with small amounts of many other insoluble proteins that are normally present in a soluble form in healthy young individuals.
Scientists at the MAC hope to gain a greater understanding of the creative brain by studying patients who are now making wonderful works of art in the face of their illnesses.
UCSF Medical Center ranks among the nation’s top 10 premier hospitals for the tenth consecutive year and is the best in Northern California, according to the new 2010-2011 America’s Best Hospitals survey conducted by <i>U.S. News & World Report</i>.
The Veterans Health Research Institute or NCIRE will present “The Brain at War: Neurocognitive Consequences of Combat” today (June 17).
UCSF Children’s Hospital ranks among the nation’s best children’s hospitals in eight specialties and is one of the top-ranked facilities in California, according to the new 2010-11 “America’s Best Children’s Hospitals” survey conducted by <i>U.S. News & World Report</i>.
The UCSF community is invited to a symposium to address unsolved health problems, such as cancer and malaria, as a tribute to the 11-year tenure of Mike Bishop, MD, former chancellor of UCSF.
Maria Dall’Era, Thierry Jahan, Isobel “Bel” Russell and Isaac Yang will receive the UCSF Medical Center Exceptional Physician Awards at a ceremony today (May 17.)
Five distinguished individuals, who were honored recently with the 2010 UCSF Medal, are featured in videos now available on YouTube.
A long-held vision came into view Monday as UCSF neuroscientists and clinical researchers shared their ambitious plans to attack debilitating neurological diseases through innovative collaborations.
UCSF researchers have created the first transgenic mouse to display the earliest signs of Parkinson’s disease using the genetic mutation that is known to accompany human forms of the disease.
UCSF’s Louann Brizendine, author of “The Male Brain” and “The Female Brain” will talk at UCSF on April 29.